Women and black patients have higher coronary artery bypass grafting (CABG) mortality rates than men and white patients, according to new research published in the Journal of the American Heart Association.

The FDA has issued a voluntary recall of valsartan, due to concerns of an impurity N-nitrosodimethylamine (NDMA), a known carcinogen, which was found in a batch of the drug manufactured in China. Valsartan is commonly used to control hypertension and heart failure.

Santa Fe cardiologist Roy Heilbron, MD, has been sentenced to more than four years in prison for medical fraud and obstruction of justice. He pleaded guilty to fraud last year.

Colorectal cancer is among the most treatable and preventable diseases, provided it is discovered early on—but screening rates continue to lag, especially among high-risk populations. A team found mailing full screening kits to individuals may improve rates when compared to the usual practice of mailing simple reminders.

New research published in the British Medical Journal suggests that increasing high resolution imaging scans are contributing to more accidentally discovered abnormalities, or "incidentalomas," which are unrelated to a patient's diagnosis and are often benign.

The National Electrical Manufacturers Association (NEMA) published its updated guidelines for measuring and reporting performance specifications of PET scanners on Friday, July 13.

The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.

With seven of the country’s 20 most prominent radiology practices having completed business deals within the last 18 months, the field is witnessing more efforts to consolidate and conserve resources than perhaps ever before.

Federal investigators say former HHS Secretary Tom Price wasted $341,000 of taxpayer money for his use of chartered jets and military aircraft, The New York Times reported Friday.

Association groups see some of CMS's new proposals as a missed opportunity to encourage the move to value-based care.